Related Experiment Videos
Correspondence: Culture of Neisseria gonorrhoeae
The Journal of Infectious Diseases
|November 1, 1973
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Observation of a new superfluid phase for 3He embedded in nematically ordered aerogel.
Nature communications·2016
Contact laser vaporization of the prostate in patients on chronic anticoagulant therapy.
Techniques in urology·1998
Reduction of length of stay and cost of transurethral resection of the prostate by early catheter removal.
British journal of urology·1996
Contact laser vaporization of the prostate: one surgeon's experience with 50 consecutive cases.
Techniques in urology·1996
Ethambutol Population Pharmacokinetics and Pharmacodynamics From a Phase 3 Confirmatory Trial for the Treatment of Tuberculosis.
The Journal of infectious diseases·2026
Population-level shift in ex vivo artemisinin susceptibility in Plasmodium falciparum: comparison of 2014-2015 and 2022-2024 surveys in northern Uganda.
The Journal of infectious diseases·2026
Carbapenemase-producing Kluyvera spp.: epidemiology of an evolving species.
The Journal of infectious diseases·2026
Low birthweight and prematurity, but not malaria chemoprevention, are associated with reduced pneumococcal vaccine immunogenicity in Ugandan infants.
The Journal of infectious diseases·2026
Expert Consensus on Controlled Human Infection Studies for Gonorrhoea.
The Journal of infectious diseases·2026
Structural DNA nanotechnology-guided spatially-ordered arrangement of aptamers on natural killer cells for solid tumor immunotherapy.
Journal of controlled release : official journal of the Controlled Release Society·2026
Antineoplastic ultrasmall Zn-doped Prussian blue mediating catalytic therapy and endogenous molecular pool modulation for tumor microenvironment regulation.
Colloids and surfaces. B, Biointerfaces·2026
Engineered nanovaccines for prophylactic and therapeutic immunotherapy against cancer and infectious disease.
Human vaccines & immunotherapeutics·2026